F. CANBOLAT Et Al. , "Evaluating of Solute Carrier Family 6 Member 4 Gene (SLC6A4) Promoter Polymorphisms with Escitalopram Plasma Levels for Precision Medicine in Major Depressive Disorder," The Journal of Neurobehavioral Sciences , vol.8, no.1, pp.62-69, 2021
CANBOLAT, F. Et Al. 2021. Evaluating of Solute Carrier Family 6 Member 4 Gene (SLC6A4) Promoter Polymorphisms with Escitalopram Plasma Levels for Precision Medicine in Major Depressive Disorder. The Journal of Neurobehavioral Sciences , vol.8, no.1 , 62-69.
CANBOLAT, F., TAŞDEMİR ERİNÇ, D. M., SERCAN DOĞAN, C., EVRENSEL, A., ULUCAN, K., Aydın, A., ... TARHAN, K. N.(2021). Evaluating of Solute Carrier Family 6 Member 4 Gene (SLC6A4) Promoter Polymorphisms with Escitalopram Plasma Levels for Precision Medicine in Major Depressive Disorder. The Journal of Neurobehavioral Sciences , vol.8, no.1, 62-69.
CANBOLAT, FADİME Et Al. "Evaluating of Solute Carrier Family 6 Member 4 Gene (SLC6A4) Promoter Polymorphisms with Escitalopram Plasma Levels for Precision Medicine in Major Depressive Disorder," The Journal of Neurobehavioral Sciences , vol.8, no.1, 62-69, 2021
CANBOLAT, FADİME Et Al. "Evaluating of Solute Carrier Family 6 Member 4 Gene (SLC6A4) Promoter Polymorphisms with Escitalopram Plasma Levels for Precision Medicine in Major Depressive Disorder." The Journal of Neurobehavioral Sciences , vol.8, no.1, pp.62-69, 2021
CANBOLAT, F. Et Al. (2021) . "Evaluating of Solute Carrier Family 6 Member 4 Gene (SLC6A4) Promoter Polymorphisms with Escitalopram Plasma Levels for Precision Medicine in Major Depressive Disorder." The Journal of Neurobehavioral Sciences , vol.8, no.1, pp.62-69.
@article{article, author={FADİME CANBOLAT Et Al. }, title={Evaluating of Solute Carrier Family 6 Member 4 Gene (SLC6A4) Promoter Polymorphisms with Escitalopram Plasma Levels for Precision Medicine in Major Depressive Disorder}, journal={The Journal of Neurobehavioral Sciences}, year=2021, pages={62-69} }